Western Standard LLC’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.04M Buy
+387,188
New +$4.41M 1.71% 17
2024
Q3
Sell
-526,266
Closed -$3.18M 22
2024
Q2
$3.18M Buy
526,266
+2,873
+0.5% +$17.7K 3.3% 12
2024
Q1
$3.07M Buy
523,393
+469,906
+879% +$2.79M 1.47% 10
2023
Q4
$419K Buy
+53,487
New +$371K 0.28% 30

Other funds holding ANGO

Western Standard LLC's ANGO Position: Q2 2026 in Review

Western Standard LLC opened a new position in AngioDynamics (ANGO) in Q2 2026: 387,188 shares worth $5.04M. The stake represents 1.71% of the portfolio and ranks #17 among its holdings. This is a return to the name: Western Standard LLC previously reported a position in ANGO as recently as Q2 2024.

Western Standard LLC first reported a position in ANGO in Q4 2023 and has held it in 4 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Western Standard LLC held 387,188 shares of AngioDynamics worth $5.04M as of Q2 2026.
  • AngioDynamics was a new Western Standard LLC position in Q2 2026.
  • AngioDynamics made up 1.71% of Western Standard LLC's portfolio in Q2 2026, its #17 holding.
  • Western Standard LLC first reported a position in AngioDynamics in Q4 2023 and has held it in 4 quarters since.
  • 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Western Standard LLC's 13F filing for Q2 2026, filed 10 Aug 2026.